Sandy Calvin
About Sandy Calvin
Sandy Calvin serves as the Senior Vice President and Chief Accounting Officer at Travere Therapeutics, a position he has held since 2022. With extensive experience in accounting and finance, he has worked in various roles at Travere Therapeutics and Amylin Pharmaceuticals over the past several years.
Current Role at Travere Therapeutics
Sandy Calvin serves as the Senior Vice President and Chief Accounting Officer at Travere Therapeutics. She has held this position since 2022, contributing to the financial leadership of the organization. Her role involves overseeing accounting functions and ensuring compliance with financial regulations. She is based in San Diego, California.
Previous Experience at Travere Therapeutics
Before her current role, Sandy Calvin worked at Travere Therapeutics in various capacities. From 2014 to 2018, she was the Executive Director, Corporate Controller. She then served as Vice President, Corporate Controller from 2018 to 2021, and briefly as Vice President, Corporate Controller & Chief Accounting Officer in 2021 before transitioning to her current position in 2022.
Experience at Amylin Pharmaceuticals
Sandy Calvin has significant experience from her tenure at Amylin Pharmaceuticals LLC. She served as the Director, San Diego Site Controller from 2012 to 2014. Prior to that, she was the Director, Accounting Operations at Amylin Pharmaceuticals Inc. from 2004 to 2012. Her roles involved managing financial operations and ensuring effective accounting practices.
Early Career and Education
Sandy Calvin began her career as a Staff Auditor at Deloitte & Touche from 1988 to 1990. She then worked at Vical, Inc. as Associate Director Accounting from 1990 to 2004. Sandy holds a Bachelor's degree in Accounting from San Diego State University, where she studied from 1983 to 1987.